Shanghai, China

Weimin Wang

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Company Ltd., Jinagsu Hengrui Medicine Co., Ltd. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weimin Wang. Retrieved from https://idiyas.com/inventor/weimin-wang-ai3s1f10

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Weimin Wang in Pharmaceutical Chemistry

Introduction: Weimin Wang, an accomplished inventor based in Shanghai, China, has made significant strides in the field of pharmaceutical chemistry. With a total of three patents to his name, his innovative work mainly focuses on the development of therapeutic agents that have profound implications in medicine.

Latest Patents: Wang's most recent patent, titled "Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof," reveals groundbreaking insights into an oxopicolinamide derivative. This invention is particularly noteworthy as it details a preparation method and pharmaceutical composition, centering on its applications as a therapeutic agent. Specifically, it functions as an inhibitor of blood coagulation factor XIa (FXIa), which is essential in the treatment of thromboembolism and related diseases. The comprehensive understanding of the general formula (AI) and the specific techniques outlined in this patent showcase Wang's commitment to advancing medical science.

Career Highlights: Weimin Wang has honed his expertise while working with renowned companies such as Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His professional endeavors in these prestigious organizations have facilitated his development and innovation within the pharmaceutical industry.

Collaborations: Throughout his career, Wang has collaborated with esteemed colleagues like Fanglong Yang and Xiaodong Li. These partnerships have undoubtedly fostered an environment conducive to creativity and innovation, allowing for the generation of ideas that push the boundaries of conventional pharmacological research.

Conclusion: Weimin Wang's inventive accomplishments exemplify the importance of innovation in medical therapeutics. Through his patents and professional collaborations, he continues to shape the future of pharmaceutical chemistry, benefiting countless individuals in need of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…